UNC/NCSU Joint Department of Biomedical Engineering, North Carolina State University, Campus Box 7115, 911 Oval Drive, Raleigh, North Carolina 27695.
Division of Biology, Chemistry, and Materials Science, US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, Maryland 20993.
Biointerphases. 2019 May 3;14(2):021007. doi: 10.1116/1.5095886.
Gelatin methacryloyl (GelMA) and lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) photoinitiator are commonly used in combination to produce a photosensitive polymer but there are concerns that must be addressed: the presence of unreacted monomer is well known to be cytotoxic, and lithium salts are known to cause acute kidney injury. In this study, acellular 10% GelMA hydrogels cross-linked with different LAP concentrations and cross-linking illumination times were evaluated for their cytotoxicity, photosensitizing potential, and elastic moduli. Alamar Blue and CyQuant Direct Cell viability assays were performed on human primary renal proximal tubule epithelial cells (hRPTECs) exposed to extracts of each formulation. UV exposure during cross-linking was not found to affect extract cytotoxicity in either assay. LAP concentration did not affect extract cytotoxicity as determined by the Alamar Blue assay but reduced hRPTEC viability in the CyQuant Direct cell assay. Photocatalytic activity of formulation extracts toward NADH oxidation was used as a screening method for photosensitizing potential; longer UV exposure durations yielded extracts with less photocatalytic activity. Finally, elastic moduli determined using nanoindentation was found to plateau to approximately 20-25 kPa after exposure to 342 mJ/cm at 2.87 mW of UV-A exposure regardless of LAP concentration. LAP at concentrations commonly used in bioprinting (<0.5% w/w) was not found to be cytotoxic although the differences in cytotoxicity evaluation determined from the two viability assays imply cell membrane damage and should be investigated further. Complete cross-linking of all formulations decreased photocatalytic activity while maintaining predictable final elastic moduli.
明胶甲基丙烯酰(GelMA)和苯基-2,4,6-三甲基苯甲酰基膦(LAP)光引发剂常用于产生光敏聚合物,但存在一些需要解决的问题:未反应的单体的存在众所周知具有细胞毒性,而锂盐已知会导致急性肾损伤。在这项研究中,评估了不同 LAP 浓度和交联光照时间交联的无细胞 10% GelMA 水凝胶的细胞毒性、光敏潜力和弹性模量。将人原代肾近端小管上皮细胞(hRPTEC)暴露于每种配方的提取物中,进行 Alamar Blue 和 CyQuant Direct 细胞活力测定。交联过程中的 UV 暴露在两种测定中均未发现会影响提取物的细胞毒性。LAP 浓度不会影响 Alamar Blue 测定中的提取物细胞毒性,但会降低 CyQuant Direct 细胞测定中的 hRPTEC 活力。制剂提取物对 NADH 氧化的光催化活性被用作光敏潜力的筛选方法;较长的 UV 暴露时间会产生光催化活性较低的提取物。最后,使用纳米压痕法确定的弹性模量在暴露于 342 mJ/cm2 的 2.87 mW 的 UV-A 照射下达到约 20-25 kPa 的平台,无论 LAP 浓度如何。在生物打印中常用浓度(<0.5% w/w)的 LAP 未被发现具有细胞毒性,尽管两种活力测定法确定的细胞毒性评估差异表明细胞膜损伤,应进一步研究。所有配方的完全交联都会降低光催化活性,同时保持可预测的最终弹性模量。